Aqualung Therapeutics
Tucson, US · Founded 2021 · Delaware corporation · 2 known investors
Find your way into Aqualung Therapeutics
Aqualung Therapeutics is an early-stage therapeutics company developing a drug discovery platform and pipeline focused on advancing human health. It is affiliated with the University of Florida biotech ecosystem.
Founders & leadership
Aqualung Therapeutics was founded in 2021 by Joe G.N. Garcia and Joe G.N. "Skip" Garcia.
JG
Joe G.N. GarciaCo-founder
JG
Joe G.N. "Skip" GarciaFounder & Chief Executive Officer
SM
Shawntela MartinezChief Financial Officer (Fractional)
AC
Augustine ChoiChief Medical Officer (Fractional)
SM
Stan MielePresident
Investors · 2
Also in the syndicate · 1
JSR Lifescienceslead
Funding
SEC filings, press & company announcements$3.1M disclosed across 1 of 2 rounds · 2021–2022
- Undisclosed amountSeries ADec 2022
JSR Lifesciences (lead)
Source ↗
▶$3.1MraisedJun 2022 · 17 investors · BiotechnologyRule 506(b)
▶$3.1MraisedJun 2022 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stan MieleExecutive Officer, Director
- Joe G.N. GarciaExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $3.1M
- Minimum investment
- $10K
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Medscape20 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Osmosis14 shared keywordsOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
Oup13 shared keywordsOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.
Companies competing with Aqualung Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 13 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2023 | $975.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2023 | $809K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2022 | $269.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2022 | $259.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2022 | $259.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2021 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2020 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2020 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2020 | $265.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2019 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2019 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2011 | $631.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Aqualung Therapeutics do?
- Aqualung Therapeutics is an early-stage therapeutics company developing a drug discovery platform and pipeline focused on advancing human health. It is affiliated with the University of Florida biotech ecosystem.
- Who founded Aqualung Therapeutics?
- Aqualung Therapeutics was founded by Joe G.N. Garcia, Joe G.N. "Skip" Garcia in 2021.
- Who are Aqualung Therapeutics's investors?
- Aqualung Therapeutics's investors include 7G BioVentures.
- How much funding has Aqualung Therapeutics raised?
- Aqualung Therapeutics has disclosed $3.1M raised across 1 of its 2 known rounds.
- Where is Aqualung Therapeutics headquartered?
- Aqualung Therapeutics is headquartered in Tucson, US.